Innovation
Alsymo aims to treat patients with pulmonary hypertension
… Alsymo aims to treat patients with pulmonary hypertension Innovation Many patients suffering from pulmonary arterial … are focusing on a drug that acts on pulmonary vascular N-methyl-D-aspartate (NMDA) receptors. Approximately 50 out of … possible for 50% of patients. The origins of Alsymo In 2011, biologist Sylvia Cohen-Kaminsky met Mouad Alami, a …Published on: